It’s disappointing that it’s financial or legal threats that compel reconsideration.
What had changed is that the NHS was facing legal action. Less than two months after the GMC had concluded – for the third time – there were no safety concerns surrounding Sam Hall’s practices at WellBN, NHS England came to a completely different conclusion. In a document seen by the New Statesman, dated 8 April 2025, NHSE told the Sussex Integrated Care Board (NHS Sussex) that it was their view that “the approach adopted by WellBN sits neither within the scope of a specialised [gender] service commissioned by NHS England” nor was it within the treatments offered under the General Medical Services contract. (This outlines the core health services GPs are required to provide.) As a consequence, WellBN, of which Hall was one of three GP partners until his departure at the end of June 2025, “should be instructed to cease offering the prescription of exogenous hormones for gender incongruence” to 16- and 17-year-olds.